Kaletra

Kaletra: an antiviral drug for the treatment of HIV infection

Kaletra is an antiviral drug that is used to treat HIV infection in adults and children over 2 years of age as part of combination therapy. The drug contains two active components - lopinavir and ritonavir, which are HIV protease inhibitors. Kaletra is manufactured by Abbott Laboratories in the UK.

However, before using Kaletra, it is necessary to take into account its contraindications and side effects. The drug is not recommended for severe liver failure, as well as in case of hypersensitivity to lopinavir, ritonavir and other components of the drug.

Among the side effects of Kaletra, disturbances in laboratory parameters, endocrine system, hematopoietic system, metabolism, nervous system, sensory organs, cardiovascular and respiratory systems, digestive organs, skin, musculoskeletal system, genitourinary system, and also other symptoms such as back pain, chest pain, chest pain, chills, facial swelling, fever, flu-like syndrome, malaise.

In addition, do not forget about possible interactions of Kaletra with other medications. For example, simultaneous use with astemizole, terfenadine, midazolam, triazolam, cisapride, pimozide, amiodarone, ergot alkaloids, flecainide, propafenone, rifampicin and drugs containing St. John's wort may lead to undesirable consequences.

In general, the choice of Kaletra in the treatment of HIV infection should be based on an individual determination of viral resistance and previous therapy. If side effects occur, seek medical attention.